The Middle East pharmaceutical market is experiencing rapid growth due to increasing healthcare investments, rising population, chronic disease prevalence, and government initiatives to strengthen healthcare infrastructure. Countries such as the United Arab Emirates, Saudi Arabia, Oman, Qatar, and Kuwait are increasingly relying on trusted global pharmaceutical partners for high-quality and affordable medicines. Among the leading